Pharmacy Report Archives - Page 34 of 148 - Becker's Hospital Review

Mark Cuban's latest system partner | 11 drugmakers rank among 'best-managed' | US bolsters IV inventory | New cancer drug approved | 5 notes on pharmacy deserts

December 9, 2024 BHR Newsletter 1. Penn Medicine partners with Mark Cuban's drug company Full story 2. 10 drugmakers among best-managed healthcare cos. Full story 3. Feds secure IV fluids from South Korea Full story 4. Rare disease patients need better care pathways.…

6 new GLP-1 findings | Calif. system settles drug error lawsuit | 2 gene therapy makers join CMS model | IV containers in short supply: FDA | CVS plans $2.5B bond sale

December 5, 2024 BHR Newsletter 1. CMS partners with 2 companies on sickle cell therapies Full story 2. UC Regents reaches $15M settlement over medication error: 5 things to know Full story 3. 6 GLP-1 study findings to know Full…

UnitedHealthcare CEO fatally shot | Pharmacy leaders' focus for next 3 years | Cuban defends disruption status | 1 in 3 pharmacies closed since 2010 | Zepbound eclipses Wegovy in weight loss results

December 4, 2024 BHR Newsletter 1. UnitedHealthcare CEO fatally shot in New York City Full story 2. Zepbound outperforms Wegovy for weight loss: Study Full story 3. US negotiated drug prices still higher than other countries: Study Full story 4.…

Diabetes group: Avoid compounded GLP-1s | 56% of pharmacists say AI will replace jobs | CVS taps pharmacy chief | Chicago system to upgrade specialty pharmacy | Va. system CEO to exit

December 3, 2024 BHR Newsletter 1. Diabetes group recommends against compounded GLP-1s Full story 2. Americans seeking new jobs reaches decade high: 5 things to know Full story 3. Ozempic is becoming cheaper Full story 4. Rare diseases can be…

A refreshed pharmacy chain model? | Top Walgreens leader exits | Hospitals to ration IV fluids after shortage ends | Another drugmaker seeks 340B changes | GLP-1's $411B conundrum

December 2, 2024 BHR Newsletter 1. An opportunity for a refreshed pharmacy chain model Full story 2. GLP-1's $411B conundrum Full story 3. Hospitals to ration IV fluids after shortage ends Full story 4. 3 themes that emerged from Becker's…

Medicare drug price differences: 5 notes | GLP-2s, explained | 40 largest US health systems | Trump taps HHS deputy secretary | 53% of US adults eligible for Ozempic, Wegovy

November 27, 2024 BHR Newsletter 1. Medicare prescription drug pricing variance: 5 things to know Full story 2. HHS invests $44M in 2 pharmaceutical companies Full story 3. GLP-2s, explained Full story 4. Becker's CPO Summit: Get 3 takeaways on tech,…

Potential risks with Singulair: FDA study | Healthcare execs: Recognize pharmacists as providers | Trump + generic drug costs: 5 notes | Medicare urged to cover GLP-1s | Alzheimer's drug trial halted

November 26, 2024 BHR Newsletter 1. Asthma drug linked to severe mental health side effects: FDA study Full story 2. Trump tariffs could drive up generic drug costs: 5 takeaways Full story 3. Controversial Alzheimer's drug trial halted Full story 4.…

NY system enhances med management | Sanofi aims to alter 340B | Fla. plan to import drugs from Canada stalls | Clonazepam recalled over label error | Who can make GLP-1s? 5 notes

November 25, 2024 BHR Newsletter 1. NYC Health + Hospitals to upgrade medication management technology Full story 2. Florida drug importation plan stalls nearly a year after approval Full story 3. Drugmakers, pharmacists battle over who gets obesity drugs: 5 things…

ASHP taps CIO | Bomb cyclone pauses pharmacy services in Wash. | 10 systems seeking pharmacy leaders | NY's plan to curb PBMs | 6 in 10 patients worry over pharmacy deserts

November 21, 2024 BHR Newsletter 1. New York cracks down on PBM drug prices Full story 2. Rising prescription costs, pharmacy closures shape consumer attitudes: Survey Full story 3. ASHP taps chief information officer Full story 4. Rare disease patients…

Systems brace for possible 340B cuts | Hospital pharmacies enter new markets | PBMs sue FTC | 1st brain-injected gene therapy approved | Wash. hospital OKs pharmacy review in settlement

November 20, 2024 BHR Newsletter 1. Health systems brace for possible 340B cuts Full story 2. 1st gene therapy delivered directly into brain approved Full story 3. PBMs sue to stop FTC's case over insulin prices Full story 4. Rare…